Este protocolo aborda a pacientes de 15 años en adelante que presentan amigdalitis crónica en el contexto de una infección estreptocócica β-hemolítica (grupo A, C o G) altamente sospechada o confirmada, una puntuación McIsaac de al menos 3, y sin alergia o incompatibilidad a la penicilina.
Con un tratamiento adecuado, la mayoría de los pacientes —especialmente adolescentes y adultos— están libres de síntomas en 48 horas.
Antibiotic therapy is indicated only in case of a highly suspected or proven b-hemolytic streptococci infection (of group A, C, or G).
For patients with sore throat in times and regions without epidemic occurrence of b-hemolytic streptococcal infection, a low regional incidence of streptococcal sequelae and a McIsaac-Score of at least 3, oral medication is recommended as follows — Age 15 years and older:
Penicillin V (3 × 0.8–1.0 Mio IU/day for 7 days)
With adequate therapy, most of the patients, especially adolescents and adults, are free of symptoms within 48 h.
DOI: 10.1007/s00405-015-3872-6
View source ↗